Literature DB >> 20586965

Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi.

Hannock Tweya1, Dickman Gareta, Fredrick Chagwera, Anne Ben-Smith, Justin Mwenyemasi, Fred Chiputula, Matthew Boxshall, Ralf Weigel, Andreas Jahn, Mina Hosseinipour, Sam Phiri.   

Abstract

OBJECTIVES: To determine the proportion of patients returning to antiretroviral treatment (ART) and factors associated with their return in a resource-limited setting.
METHODS: Between September 2006 and March 2009, at two ART-providing facilities in Lilongwe, Malawi, we identified patients who had missed clinic appointments by more than 3 weeks and therefore would have run out of antiretroviral drugs. We traced these individuals, documented reasons for missed appointments and, where appropriate, arranged another ART clinic appointment.
RESULTS: Between April 2006 and March 2009, 2653 patients on ART had missed 3098 scheduled appointments. We successfully traced 85%, of whom 30% had died. Of the 1580 patients found alive, 25% had transferred to another ART clinic, 21% had collected drugs from other sources, 11% had treatment gaps; 40% had stopped taking drugs, 1% had not started taking drugs despite collecting them and 2% refused to be interviewed. Of the 1158 LTFU patients who had not died, transferred out or declined to be interviewed, 89% promised to return to their ART clinic and 74% actually did. The probability of returning to the clinic was significantly associated with being women, aged over 39 at ART initiation and having either treatment gaps or uninterrupted therapy. The B2C project reduced the proportion of patients finally classified as LTFU by 59%.
CONCLUSION: Early active follow-up of LTFU patients resulted in marked improvement in known patient outcomes and improved retention in the treatment programme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586965     DOI: 10.1111/j.1365-3156.2010.02509.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  53 in total

1.  Operational research training: the course and beyond.

Authors:  K Bissell; A D Harries; A J Reid; M Edginton; S G Hinderaker; S Satyanarayana; D A Enarson; R Zachariah
Journal:  Public Health Action       Date:  2012-09-21

2.  Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.

Authors:  Lyson Tenthani; Andreas D Haas; Olivia Keiser; Hannock Tweya; Andreas Jahn; Joep J van Oosterhout; Frank Chimbwandira; Zengani Chirwa; Wingston Ng'ambi; Alan Bakali; Sam Phiri; Landon Myer; Fabio Valeri; Marcel Zwahlen; Gilles Wandeler
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

3.  Improving PMTCT uptake and retention services through novel approaches in peer-based family-supported care in the clinic and community: a 3-arm cluster randomized trial (PURE Malawi).

Authors:  Nora E Rosenberg; Monique van Lettow; Hannock Tweya; Atupele Kapito-Tembo; Cassandre Man Bourdon; Fabian Cataldo; Levison Chiwaula; Veena Sampathkumar; Clement Trapence; Virginia Kayoyo; Florence Kasende; Blessings Kaunda; Colin Speight; Erik Schouten; Michael Eliya; Mina Hosseinipour; Sam Phiri
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

4.  A home tracing program for contacts of people with tuberculosis or HIV and patients lost to care.

Authors:  C B Deery; C F Hanrahan; K Selibas; J Bassett; I Sanne; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

5.  All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.

Authors:  Nanina Anderegg; Leigh F Johnson; Elizabeth Zaniewski; Keri N Althoff; Eric Balestre; Matthew Law; Denis Nash; Bryan E Shepherd; Constantin T Yiannoutsos; Matthias Egger
Journal:  AIDS       Date:  2017-04       Impact factor: 4.177

6.  Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.

Authors:  Jason Kessler; Kimberly Nucifora; Lingfeng Li; Lauren Uhler; Scott Braithwaite
Journal:  Value Health       Date:  2015-11-17       Impact factor: 5.725

7.  Implementation and operational research: evaluating outcomes of patients lost to follow-up in a large comprehensive care treatment program in western Kenya.

Authors:  Beth Rachlis; Daniel Ochieng; Elvin Geng; Elyne Rotich; Vincent Ochieng; Beryl Maritim; Samson Ndege; Violet Naanyu; Jeffrey N Martin; Alfred Keter; Paul Ayuo; Lameck Diero; Monicah Nyambura; Paula Braitstein
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

8.  Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.

Authors:  Nellie Wadonda-Kabondo; Diane Bennett; Joep J van Oosterhout; Kundai Moyo; Mina Hosseinipour; Josh Devos; Zhiyong Zhou; John Aberle-Grasse; Thomas R Warne; Clement Mtika; Ben Chilima; Richard Banda; Olesi Pasulani; Carol Porter; Sam Phiri; Andreas Jahn; Debbie Kamwendo; Michael R Jordan; Storn Kabuluzi; Frank Chimbwandira; Mathew Kagoli; Blackson Matatiyo; Austin Demby; Chunfu Yang
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

9.  Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi.

Authors:  Janne Estill; Hannock Tweya; Matthias Egger; Gilles Wandeler; Caryl Feldacker; Leigh F Johnson; Nello Blaser; Luisa Salazar Vizcaya; Sam Phiri; Olivia Keiser
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

10.  High Cancer Burden Among Antiretroviral Therapy Users in Malawi: A Record Linkage Study of Observational Human Immunodeficiency Virus Cohorts and Cancer Registry Data.

Authors:  Marie-Josèphe Horner; Steady Chasimpha; Adrian Spoerri; Jessie Edwards; Julia Bohlius; Hannock Tweya; Petros Tembo; Franklin Nkhambule; Eddie Moffo Phiri; William C Miller; Kennedy Malisita; Sam Phiri; Charles Dzamalala; Andrew F Olshan; Satish Gopal
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.